Although clinicians using needle electrodes for sick term infants reported minimal evidence of discomfort [12] and negligible infection rate for long-term application, [46] in vulnerable preterm ...
The US Food and Drug Administration (FDA) has granted breakthrough device designation to CergenX’s AI-powered tool for neonatal brain scans. The Irish startup will now be in line for prioritised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback